Pages that link to "Q33397988"
Jump to navigation
Jump to search
The following pages link to Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections (Q33397988):
Displaying 50 items.
- Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients (Q24245120) (← links)
- Thrombocytopenia and drugs (Q33449455) (← links)
- Studies of cytomegalovirus infection in renal allograft recipients (Q33476864) (← links)
- Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients (Q33477021) (← links)
- New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients (Q33812425) (← links)
- Interferon-alpha-induced acute renal allograft rejection (Q34232396) (← links)
- Interferon and cytotoxic chemotherapy for the treatment of post-transplant lymphoproliferative disorder (Q34275888) (← links)
- Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies (Q34291445) (← links)
- OKT3 and viral disease in pediatric liver transplant recipients (Q34407162) (← links)
- Infections and solid organ transplant rejection: a cause-and-effect relationship? (Q34807471) (← links)
- Cytomegalovirus infection and disease after liver transplantation (Q35227146) (← links)
- Efficacy of S26308 against guinea pig cytomegalovirus infection (Q35303927) (← links)
- Infections in solid-organ transplant recipients (Q35376486) (← links)
- High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients (Q35608425) (← links)
- Effect of acyclovir and interferon on human hematopoietic progenitor cells (Q35673321) (← links)
- Viral prophylaxis in organ transplant patients (Q35962532) (← links)
- Protective effect of low-dose interferon against neonatal murine cytomegalovirus infection (Q36423122) (← links)
- The prevention of cytomegalovirus disease in renal transplantation (Q36596089) (← links)
- Interferon in the Treatment of AIDS-Associated Kaposi's Sarcoma: The American Experience (Q36612279) (← links)
- Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. (Q37159078) (← links)
- Prevention of cytomegalovirus infection in the pediatric renal transplant recipient (Q37176362) (← links)
- Detection of cytomegalovirus in peripheral leukocytes by different methods (Q37179216) (← links)
- Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention (Q38052946) (← links)
- Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies (Q38194499) (← links)
- Noninfectious pulmonary complications of infection with the human immunodeficiency virus (Q38747039) (← links)
- Treatment and prevention of virus infections in immunosuppressed patients. (Q39498836) (← links)
- Molecular biology and immunology of cytomegalovirus (Q39509644) (← links)
- Therapeutic control of viral infections: Chemotherapy, interferon and gamma globulin (Q39589455) (← links)
- Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. (Q39820778) (← links)
- Interferons, a group of multiple lymphokines (Q40075831) (← links)
- Treatment of mucocutaneous herpes simplex infections (Q40076516) (← links)
- Prevention of herpes simplex virus diseases in man (Q40081296) (← links)
- What's new. (Q40097955) (← links)
- Interferon therapy: Pharmacokinetic and pharmacological aspects (Q40099867) (← links)
- Interferon as an Antiviral and Anti-tumor Therapeutic Agent (Q40100488) (← links)
- Antiviral agents: An update—Part 2 (Q40100907) (← links)
- Interferons and interferon inducers: development of clinical usefulness and therapeutic promise (Q40102336) (← links)
- An assessment of antiviral drugs for the management of infectious diseases in humans (Q40102767) (← links)
- Cancer 1980: Achievements, challenges, and prospects (Q40103148) (← links)
- The pathogenesis of acute, latent and recurrent herpes simplex virus infections (Q40104231) (← links)
- Interferon—Present and Future Prospects (Q40109995) (← links)
- Properties of antiviral agents. 2 (Q40111283) (← links)
- Toxicologic evaluations of recombinant liver-targeting interferon IFN-CSP: Genotoxicity and tegenicratoity (Q40122263) (← links)
- Host defense abnormalities predisposing the patient to infection (Q40176703) (← links)
- Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients (Q40197928) (← links)
- The clinical implications of human interferon. (Q40208976) (← links)
- Use of a modified shell vial technique to quantitate cytomegalovirus viremia in a population of solid-organ transplant recipients (Q40214747) (← links)
- Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancer (Q40784610) (← links)
- Infectious disease complications of renal transplantation (Q40856911) (← links)
- Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease (Q40860030) (← links)